Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

FEMY

Femasys (FEMY)

Femasys Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:FEMY
일자시간출처헤드라인심볼기업
2024/04/1821:30GlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare InitiativesNASDAQ:FEMYFemasys Inc
2024/03/2905:05GlobeNewswire Inc.Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
2024/03/2122:00GlobeNewswire Inc.Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment LandscapeNASDAQ:FEMYFemasys Inc
2024/03/2021:15GlobeNewswire Inc.Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of InfertilityNASDAQ:FEMYFemasys Inc
2024/03/1322:00GlobeNewswire Inc.Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024NASDAQ:FEMYFemasys Inc
2024/03/0623:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
2024/03/0623:00GlobeNewswire Inc.Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility SolutionNASDAQ:FEMYFemasys Inc
2024/02/2823:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
2024/02/1411:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
2024/02/1411:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
2024/02/0622:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
2024/02/0306:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
2024/02/0306:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
2024/02/0306:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
2023/12/1114:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FEMYFemasys Inc
2023/12/0823:28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
2023/12/0107:17Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FEMYFemasys Inc
2023/11/3006:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
2023/11/2306:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
2023/11/2306:33Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
2023/11/2306:12Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:FEMYFemasys Inc
2023/11/2207:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
2023/11/1607:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
2023/11/1522:30Business WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:FEMYFemasys Inc
2023/11/0210:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
2023/10/1121:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
2023/10/0322:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
2023/10/0322:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
2023/09/2721:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
2023/09/0706:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
 검색 관련기사 보기:NASDAQ:FEMY